Proclara Biosciences (Formerly known as NeuroPhage)
222 Third Street
Proclara Biosciences is pioneering powerful new methods for treating neurodegenerative diseases long thought to be intractable. We seek talented and ambitious individuals who share our passion for innovative science and our commitment to transforming the lives of patients suffering from serious protein misfolding diseases.
CEO: Franz Heft
CSO: Richard Fisher
Please click here for Proclara job opportunities.
Please click here for clinical trial information.